RESUMEN
Previous studies into third trophic level exposure of Chrysoperla spp. (Neuroptera: Chrysopidae) to Cry1Ab proteins produced by Bt crops yielded contradicting results. These contradictions were largely ascribed to differences in prey quality and exposure methods. In this study, we used healthy prey to expose lacewing larvae to Cry1Ab protein produced by Bt maize, and also determined the concentration of this protein at different trophic levels. Experiments were conducted in which Chrysoperla pudica (Navás) larvae were fed different diets which included aphids and healthy Bt-resistant Busseola fusca (Fuller) (Lepidoptera: Noctuidae) larvae feeding on Bt maize tissue. Lacewing larval and pupal development times as well as overall mortality were determined. The concentration of Cry1Ab protein in B. fusca larvae were fourfold reduced compared with that in leaf tissue and was below detection level in lacewing larvae. Survival to the pupal stage was higher than 96% in all treatments. Larval and pupal development periods did not differ significantly between treatments in which prey fed on Bt or non-Bt maize. This study showed feeding on healthy prey that consumed Cry1Ab protein has no adverse effect on the biology of C. pudica.
Asunto(s)
Bacillus thuringiensis/química , Proteínas Bacterianas/efectos adversos , Endotoxinas/efectos adversos , Proteínas Hemolisinas/efectos adversos , Insectos/efectos de los fármacos , Control Biológico de Vectores , Plantas Modificadas Genéticamente/efectos adversos , Zea mays/química , Animales , Áfidos/química , Bacillus thuringiensis/genética , Toxinas de Bacillus thuringiensis , Dieta , Insectos/crecimiento & desarrollo , Larva/química , Larva/efectos de los fármacos , Larva/crecimiento & desarrollo , Mariposas Nocturnas/química , Plantas Modificadas Genéticamente/química , Pupa/efectos de los fármacos , Pupa/crecimiento & desarrollo , Zea mays/genéticaRESUMEN
AIM: To determine the disease causing gene defects in two patients with Meesmann's corneal dystrophy. METHODS: Mutational analysis of domains 1A and 2B of the keratin 3 (K3) and keratin 12 (K12) genes from two patients with Meesmann's corneal dystrophy was performed by polymerase chain reaction amplification and direct sequencing. RESULTS: Novel mutations of the K12 gene were identified in both patients. In one patient a heterozygous point mutation (429A-->C = Arg135Ser) was found in the 1A domain of the K12 gene. This mutation was confirmed by restriction digestion. In the second patient a heterozygous 27 bp duplication was found inserted in the 2B domain at nucleotide position 1222 (1222ins27) of the K12 gene. This mutation was confirmed by gel electrophoresis. The mutations were not present in unaffected controls. CONCLUSION: Novel K12 mutations were linked to Meesmann's corneal dystrophy in two different patients. A missense mutation replacing a highly conserved arginine residue in the beginning of the helix initiation motif was found in one patient, and an insertion mutation, consisting of a duplication of 27 nucleotides, was found before the helix termination motif in the other.
Asunto(s)
Distrofias Hereditarias de la Córnea/genética , Duplicación de Gen , Queratinas/genética , Mutación Missense , Secuencia de Bases , Estudios de Casos y Controles , Niño , Análisis Mutacional de ADN , Femenino , Humanos , Queratina-12 , Datos de Secuencia MolecularRESUMEN
UNLABELLED: Colonoscopy is one of the most frequently performed outpatient procedures in the United States. This study was designed to test the hypothesis that a remifentanil infusion would be superior to boluses of meperidine in older patients undergoing ambulatory colonoscopy. One hundred ASA physical status I-IV patients undergoing colonoscopy were randomized in this double-blinded study to receive either remifentanil infusions (n = 49) or titrated boluses of meperidine (n = 51). Patient tolerance was assessed using physiologic variables and side effects associated with opioid analgesia. Verbal pain/anxiety and patient/operator satisfaction were also assessed. As a group, the physiologic characteristics demonstrated no significant differences in the response to the colonoscopy procedure. Although the patient and operator satisfaction surveys were similar between groups, the incidences of tachycardia, hypotension, and nausea were less and the adjusted verbal pain and anxiety scores were more in the Remifentanil group compared with the Meperidine group. This study demonstrates that remifentanil and meperidine were equally well tolerated in older patients undergoing ambulatory colonoscopy when administered by an anesthesia provider. The differences in the pharmakinetics of remifentanil and meperidine most likely account for the differences noted between the two treatment groups. IMPLICATIONS: Remifentanil infusions and meperidine boluses are equally well tolerated in older patients undergoing ambulatory colonoscopy when administered by an anesthesia provider.
Asunto(s)
Adyuvantes Anestésicos/administración & dosificación , Analgésicos Opioides/administración & dosificación , Anestésicos Intravenosos/administración & dosificación , Colonoscopía/métodos , Meperidina/administración & dosificación , Piperidinas/administración & dosificación , Adyuvantes Anestésicos/efectos adversos , Anciano , Atención Ambulatoria , Analgésicos Opioides/efectos adversos , Anestésicos Intravenosos/efectos adversos , Ansiedad/tratamiento farmacológico , Ansiedad/etiología , Colonoscopía/efectos adversos , Método Doble Ciego , Femenino , Humanos , Infusiones Intravenosas , Inyecciones Intravenosas , Masculino , Meperidina/efectos adversos , Persona de Mediana Edad , Dolor/tratamiento farmacológico , Dolor/etiología , Dimensión del Dolor/efectos de los fármacos , Piperidinas/efectos adversos , RemifentaniloRESUMEN
The major enzymes involved in the degradation of heme were identified in human platelets. It was determined that heme oxygenase activity levels in umbilical cord blood platelets were higher, whereas biliverdin reductase activity levels were comparable with that found in platelets from adults. In membranes prepared from adenosine diphosphate-activated platelets, UDP-glucuronic acid-dependent bilirubin conjugation was detected, whereas activity was negligible in unactivated platelets and undetected in serum and heat-inactivated platelets, and in platelets prepared from umbilical cord blood. Platelet fractions were analyzed by Western blot and shown to express heme oxygenase, biliverdin reductase, and UDP-glucuronosyltransferases, and there was concordance with known developmental profiles found in other tissues. Heme oxygenase expression was higher, whereas UGT expression was lower, in neonatal compared with adult platelets. These data suggest that platelets are involved in multiple steps of heme and bilirubin metabolism and that developmental regulation of these enzymes may be similar to that in other human tissues.